Xtalks Webinars

Xtalks Webinars Xtalks — The Life Science Community™ brings together professionals across pharma, biotech, medtech, healthcare and research.

Join our community to access news, blogs, webinars, jobs, videos and more. Xtalks — The Life Science Community™ is where life science professionals come to learn, connect and be inspired. We cover the full life sciences sector, from pharma and biotech to medtech, healthcare and research. We provide a platform for peer perspectives and thought leadership through a combination of editorial, expert-l

ed webinars, podcasts, videos, interviews and job listings. All Xtalks content is created to support professionals in a fast-evolving industry. Join our community to stay informed and be part of the dialogue shaping the future of life sciences.

09/04/2026

Master compliant patient interviews within live clinical trials with Jens Harald Kongsø, Julie Perch and Linda Nelsen in this webinar hosted by CLINIGMA.

As regulators intensify expectations for patient-focused evidence, sponsors must capture authentic insights without compromising trial integrity or site operations. Learn the practical foundations for embedding in-trial interviews into protocol-driven, GCP-compliant workflows.

Register for this webinar to learn how to align interview objectives, protocol design, scheduling, safety pathways, and archiving for compliant ex*****on: https://buff.ly/HyLqEIk

09/04/2026

Navigate obesity trial differentiation beyond weight loss with Todd Rudo, MD, Vic Patel, MD, PhD, Brian K. Rundle, PhD and Mark W. Tengowski, DVM, MS, PhD in this webinar hosted by Clario.

As obesity and type 2 diabetes pipelines accelerate, sponsors must demonstrate a more complete treatment profile than weight and glycemic outcomes alone. Phase-appropriate endpoints can reveal earlier safety and efficacy signals while building differentiated, regulator-ready evidence across development.

Register for this webinar to learn how to integrate patient experience, glucose, cardiac and imaging data to optimize dose selection, study design and late-phase differentiation: https://buff.ly/1DMzWuB

09/03/2026

Transform complex biomarker strategies into trial-ready clinical advantage with Jorge Marques Signes, PhD in this webinar hosted by Quanterix.

As precision medicine expands, analytical performance alone is no longer enough. Clinical teams need validated, scalable biomarker workflows that strengthen patient stratification, reduce development risk, and generate decision-ready data across the trial continuum.

Register for this webinar to learn how operational precision biomarkers can improve trial enrichment and translate discovery into validated clinical solutions: https://buff.ly/zdpRIbA

09/03/2026

Navigate accelerated approval complexity with Seth DePuy, PhD and Paulla Dennis in this webinar hosted by Premier Research.

Accelerated approval is regaining momentum, but evolving FDA expectations demand more than promising early evidence. Sponsors must align clinical, regulatory, operational, confirmatory trial, inspection readiness and CMC strategy well before submission.

Register for this webinar to learn how recent FDA initiatives affect readiness and how early cross-functional planning can strengthen confirmatory trial strategy: https://buff.ly/egsJcY1

09/02/2026

Navigate the hidden barriers to faster therapy access with Paul Battaglia and Lisa Skinner in this webinar hosted by Elusa Health.

Specialty and rare disease programs cannot afford access workflows built on incomplete data, superficial metrics, or automation without human verification. Learn how to assess vendor readiness, protect continuity of care, and distinguish polished reporting from meaningful patient outcomes.

Register for this webinar to learn how to evaluate hub vendors, identify access risks, and improve speed to therapy with a practical readiness framework: https://buff.ly/ju11dNr

Gout is active even between flares. James Mackay of Crystalys Therapeutics explains how uric acid can continue to build ...
09/01/2026

Gout is active even between flares. James Mackay of Crystalys Therapeutics explains how uric acid can continue to build up over time, why this complicates treatment adherence and what it means for clinical trial design. Learn more: https://buff.ly/bIKuam9

09/01/2026

Transform safety operations amid rising pharmacovigilance complexity with Ian Kovacs, PhD, Georgia Kolangi, MSc, Rosanna Eccel and Ankur Sharma in this webinar hosted by Allucent.

Expanding data sources, increasing case volumes, and inspection-readiness demands are reshaping pharmacovigilance operations. Explore practical AI applications that improve information flow, workflow visibility, and operational efficiency while preserving governance and human accountability.

Register for this webinar to learn how AI can strengthen pharmacovigilance workflows while maintaining patient safety, compliance, and oversight: https://buff.ly/ZkXc1R3

What could it take for antibody-drug conjugates to move into earlier lines of colorectal cancer treatment? Sean McCarthy...
09/01/2026

What could it take for antibody-drug conjugates to move into earlier lines of colorectal cancer treatment? Sean McCarthy, CEO and Chairman of CytomX Therapeutics, discusses antibody-drug conjugate (ADC) design, and highly focused clinical research and evolving endpoints, including the potential role of ctDNA. Learn more: https://buff.ly/736F8I3

08/31/2026

Master post-market compliance risk with Etienne Nichols in this webinar hosted by Greenlight Guru.

As regulatory scrutiny intensifies, disconnected complaint handling, surveillance, and reporting workflows can turn isolated signals into costly compliance exposure. A resilient QMS helps teams detect trends early, sustain inspection readiness, and protect device availability.

Register for this webinar to learn how to strengthen post-market surveillance, evaluate reportability, and remediate systemic quality gaps: https://buff.ly/7kX3We3

08/28/2026

Master early CMC decisions before they become downstream liabilities with Xiao-Ping Dai, PhD and Dr. Ellen Hilgenberg in this webinar hosted by ProBioGen.

CMC risks often originate long before manufacturing, in cell line development, process design, formulation, analytics, and tech transfer choices made without full visibility into scale-up consequences. Learn how stage-appropriate strategy can reduce rework, protect timelines, and strengthen manufacturing readiness.

Register for this webinar to learn how early CMC decisions shape downstream risk and how to align strategy with your program stage: https://buff.ly/7FnUhHi

Address

1235 Bay Street Suite 802
Toronto, ON
M5R3K4

Telephone

416-977-6555

Website

Alerts

Be the first to know and let us send you an email when Xtalks Webinars posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Xtalks Webinars:

Shortcuts

Share

Category